NOVALIQ GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.novaliq.de
CyclASol® Phase 1 Study
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CyclASol®Drug: Placebo (vehicle)
- First Posted Date
- 2014-04-14
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- Novaliq GmbH
- Target Recruit Count
- 18
- Registration Number
- NCT02113293
NovaTears® Eye Drops Observational Study
Completed
- Conditions
- Dry Eye Disease
- Interventions
- Device: NovaTears® Eye Drops
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- Novaliq GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT02111928
- Locations
- 🇩🇪
Praxis Dr. Kaercher, Heidelberg, Germany
🇩🇪Zentrum fuer Augenheilkunde Uniklinik Koeln, Koeln, Germany
© Copyright 2025. All Rights Reserved by MedPath